MyFinsight
Home
Compare
Blog
About
628fe2259e1c5d448ba8cd54_mpt_logo_2020rev_RGB-1-svg
MEDICAL PROPERTIES TRUST INC (MPT)
628fe2259e1c5d448ba8cd54_mpt_logo_2020rev_RGB-1-svg
MEDICAL PROPERTIES TRUST INC (MPT)
Income Statement
|
Cash Flow
|
Balance Sheet
|
Ratios
|
Compare
Cash Flow Overview
Unit: Thousand (K) dollars
Positive Cash Flow Breakdown
Depreciation and amortization
Depreciation and amortization
Proceeds received from repayment...
Others
Negative Cash Flow Breakdown
Investment in loans receivable
Straight-line rent revenue and o...
Accounts payable and accrued exp...
Others
Subscribe for Financial Insights
Page 1
Quarterly
123
Page 1
Cash Flow
2026-06-30
2026-03-31
2025-12-31
2025-09-30
Depreciation and amortization
73,625
73,348
69,672
69,476
Amortization of deferred financing costs and debt discount
6,565
6,983
6,919
6,862
Straight-line rent revenue from operating and finance leases
-
-
-
37,916
Straight-line rent revenue and other
-
-
158,172
-
Straight-line rent revenue from operating and finance leases
34,707
35,578
-
-
Share Based Compensation
4,861
573
-5,118
12,342
Gain on sale of real estate
6,462
-790
1,389
-9,115
Real estate and other impairment charges, net
16,929
19,506
26,815
167,132
Equity interest real estate impairment
-
-
-
0
Straight-line rent and other write-off
-
-
11,054
-
Debt refinancing and unutilized financing costs
-
0
0
3,629
Tax rate changes and other
0
-45,155
-261
-10,970
Non-cash fair value adjustments
11,042
-5,568
-16,928
123,370
Other adjustments
7,738
1,596
-17,304
4,409
Interest and rent receivables
194
-905
1,194
-8,305
Other assets
2,837
-556
-8,215
-10,057
Accounts payable and accrued expenses
5,138
-61,809
67,399
-33,841
Deferred revenue
-1,490
-321
-2,523
-914
Depreciation and amortization
146,973
-
-
-
Amortization of deferred financing costs and debt discount
13,548
-
-
-
Straight-line rent revenue and other
70,285
-
-
-
Stock / unit-based compensation expense
5,434
-
-
-
Gain on sale of real estate
5,672
-
-
-
Real estate and other impairment charges, net
36,435
-
-
-
Tax rate changes and other
-45,155
-
-
-
Non-cash fair value adjustments
5,474
-
-
-
Other adjustments
9,334
-
-
-
Interest and rent receivables
-711
-
-
-
Other assets
2,281
-
-
-
Accounts payable and accrued expenses
-56,671
-
-
-
Deferred revenue
-1,811
-
-
-
Net income (loss)
-2,288
33,107
17,597
-77,450
Net cash (used for) provided by operating activities
-
-14,259
160,064
18,572
Net income (loss)
30,819
-
-
-
Cash paid for acquisitions and other related investments
-
29,322
32,000
7,760
Net cash provided by operating activities
48,185
-
-
-
Net proceeds from sale of real estate
-
18,500
23,589
49,043
Cash paid for acquisitions and other related investments
29,322
-
-
-
Principal received from sale and repayment of loans receivable
-
-
106,260
7,049
Proceeds received from repayment of loans receivable
-
48,651
-
-
Net proceeds from sale of real estate
18,900
-
-
-
Investment in loans receivable
-
71,024
46,778
106,539
Proceeds received from repayment of loans receivable
62,895
-
-
-
Construction in progress and other
-
-
-
20,124
Investment in loans receivable
146,001
-
-
-
Proceeds from sale and return of equity investments
-
-
-
0
Construction in progress and other
7,471
12,717
80,003
-
Capital additions and other investments, net
14,524
30,864
39,684
34,069
Net cash used for investing activities
-82,328
-76,776
-7,869
-256,869
Proceeds from term debt
0
0
0
2,512,970
Payments of term debt
0
0
0
2,252,731
Revolving credit facility, net
55,000
30,000
70,000
171,530
Dividends / distribution paid
54,255
55,351
48,419
144,840
Lease deposits and other obligations to tenants
495
-4,414
5,677
-505
Offering costs
137
39
83
543
Repurchase of common stock / unit
-
-
23,441
-
Stock / unit vesting - satisfaction of tax withholdings
984
1,792
996
733
Repurchase of common stock / unit
6,123
-
-
-
Payment of debt refinancing and deferred financing costs and other financing activities
-1,310
-456
-100,803
50,218
Net cash (used for) provided by financing activities
-8,304
-23,224
-8,983
237,064
(decrease) increase in cash, cash equivalents, and restricted cash for period
-28,188
-114,259
143,212
-111,022
Effect of exchange rate changes
-335
-1,785
1,150
-2,253
Cash, cash equivalents, and restricted cash at beginning of period
427,951
543,995
676,485
676,485
Cash, cash equivalents, and restricted cash at end of period
399,428
427,951
543,995
399,633
Interest paid, capitalized
-
-
12,920
-
Interest paid
105,447
174,061
65,125
172,819
Certain obligations and receivable satisfied and real estate sold
-
-
50,000
-
Real estate and other assets provided in property exchange
158,706
-
-
-
Lease incentive provided
-
-
50,000
-
Real estate acquired in property exchange
165,500
-
-
-
Dividends declared, unpaid
-
-
48,387
-
Dividends / distributions declared, unpaid
54,182
54,255
-
48,419
Cash and cash equivalents at beginning of period
425,001
540,859
673,482
673,482
Restricted cash, included in other assets at beginning of period
2,950
3,136
3,003
3,003
Cash, cash equivalents, and restricted cash at beginning of period
427,951
543,995
676,485
676,485
Cash and cash equivalents at end of period
396,558
425,001
540,859
396,577
Restricted cash, included in other assets at end of period
2,870
2,950
3,136
3,056
Cash, cash equivalents, and restricted cash at end of period
399,428
427,951
543,995
399,633
Page 1
Unit: Thousand (K) dollars (except for numbers of shares and EPS). Numbers labeled with * are estimated quarterly values.
Page 1
Buy us a coffee
Time Plot
Show the time plot by selecting a row from the table.
Cash Flow
something is missing
$33,107K
Depreciation and
amortization
$146,973K
(115.38%↑ Y/Y)
Depreciation and
amortization
$73,625K
(7.89%↑ Y/Y)
Real estate and other
impairment charges, net
$36,435K
(1819.65%↑ Y/Y)
Net income (loss)
$30,819K
Real estate and other
impairment charges, net
$16,929K
(791.94%↑ Y/Y)
Amortization of deferred
financing costs and debt...
$13,548K
(102.03%↑ Y/Y)
Non-cash fair value
adjustments
$11,042K
(-89.85%↓ Y/Y)
Amortization of deferred
financing costs and debt...
$6,565K
(-2.10%↓ Y/Y)
Non-cash fair value
adjustments
$5,474K
(-94.97%↓ Y/Y)
Stock / unit-based
compensation expense
$5,434K
(534.07%↑ Y/Y)
Accounts payable and
accrued expenses
$5,138K
(-78.16%↓ Y/Y)
Share Based
Compensation
$4,861K
(467.21%↑ Y/Y)
Interest and rent
receivables
-$711K
(-134.50%↓ Y/Y)
Canceled cashflow
$2,288K
Net cash provided by
operating activities
$48,185K
(-6.88%↓ Y/Y)
something is missing
$14,259K
Canceled cashflow
$309,369K
Net income (loss)
-$2,288K
(97.67%↑ Y/Y)
(decrease) increase in
cash, cash...
-$28,188K
(83.93%↑ Y/Y)
Canceled cashflow
$62,444K
Proceeds received from
repayment of loans...
$62,895K
something is missing
$33,195K
Net proceeds from
sale of real estate
$18,900K
(-32.69%↓ Y/Y)
Revolving credit
facility, net
$55,000K
(153.97%↑ Y/Y)
Straight-line rent revenue and
other
$70,285K
something is missing
-$64,732K
Accounts payable and
accrued expenses
-$56,671K
(-340.93%↓ Y/Y)
Tax rate changes and
other
-$45,155K
(-237757.89%↓ Y/Y)
Straight-line rent revenue
from operating and...
$34,707K
(-15.67%↓ Y/Y)
Other adjustments
$9,334K
(19.85%↑ Y/Y)
Other adjustments
$7,738K
(-0.64%↓ Y/Y)
Gain on sale of real
estate
$6,462K
(23.98%↑ Y/Y)
Gain on sale of real
estate
$5,672K
(8.83%↑ Y/Y)
Other assets
$2,837K
(88.01%↑ Y/Y)
Other assets
$2,281K
(51.16%↑ Y/Y)
Deferred revenue
-$1,811K
(22.74%↑ Y/Y)
Deferred revenue
-$1,490K
(36.43%↑ Y/Y)
Interest and rent
receivables
$194K
(-90.59%↓ Y/Y)
Net cash used for
investing activities
-$82,328K
Canceled cashflow
$114,990K
Net cash (used for)
provided by financing...
-$8,304K
Canceled cashflow
$55,000K
Investment in loans
receivable
$146,001K
(376.58%↑ Y/Y)
Cash paid for
acquisitions and other...
$29,322K
(-53.47%↓ Y/Y)
Capital additions and
other investments,...
$14,524K
(401.27%↑ Y/Y)
Construction in progress and
other
$7,471K
(-48.72%↓ Y/Y)
Dividends / distribution
paid
$54,255K
(12.13%↑ Y/Y)
Repurchase of common stock /
unit
$6,123K
Payment of debt
refinancing and deferred...
-$1,310K
(-148.88%↓ Y/Y)
Stock / unit vesting -
satisfaction of tax...
$984K
(115.79%↑ Y/Y)
Lease deposits and
other obligations to...
$495K
(-61.12%↓ Y/Y)
Offering costs
$137K
(35.64%↑ Y/Y)
Buy us a coffee
🚨
Price Alert:
The stock price dropped by 10.37% after the earning call.
Show more